Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
66
TCBI Quote, Financials, Valuation and Earnings
Last price:
$104.65
Seasonality move
:
-2.35%
Day range:
$104.35 - $106.34
52-week range:
$59.37 - $108.92
Dividend yield:
0%
P/E ratio:
15.37x
P/S ratio:
2.41x
P/B ratio:
1.39x
Volume:
702.7K
Avg. volume:
446.6K
1-year change:
26.05%
Market cap:
$4.6B
Revenue:
$2B
EPS (TTM):
$6.80
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.3B | $1.8B | $1.9B | $2B | |
| Revenue Growth (YoY) | -18.31% | 23.63% | 42.67% | 8.16% | 3.38% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | $248.5M | $489K | -$179.6M | -- | |
| Operating Expenses | -$350.1M | -$183.2M | -$246.6M | -$286.6M | -$432.7M | |
| Operating Income | $350.1M | $183.2M | $246.6M | $286.6M | $432.7M | |
| Net Interest Expenses | $42.1M | $77.8M | $128M | $92.1M | $45.4M | |
| EBT. Incl. Unusual Items | $338.1M | $431.8M | $246.6M | $107.1M | $432.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $84.1M | $99.3M | $57.5M | $29.6M | $102.5M | |
| Net Income to Company | $253.9M | $332.5M | $189.1M | $77.5M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $253.9M | $332.5M | $189.1M | $77.5M | $330.2M | |
| Basic EPS (Cont. Ops) | $4.65 | $6.25 | $3.58 | $1.29 | $6.86 | |
| Diluted EPS (Cont. Ops) | $4.60 | $6.18 | $3.54 | $1.28 | $6.79 | |
| Weighted Average Basic Share | $50.6M | $50.5M | $48.1M | $46.6M | -- | |
| Weighted Average Diluted Share | $51.1M | $51M | $48.6M | $47M | $46.1M | |
| EBITDA | -- | $745.5M | $1B | $989.5M | -- | |
| EBIT | $445.8M | $700.2M | $962.4M | $935.3M | $1.2B | |
| Revenue (Reported) | $1B | $1.3B | $1.8B | $1.9B | $2B | |
| Operating Income (Reported) | $350.1M | $183.2M | $246.6M | $286.6M | $432.7M | |
| Operating Income (Adjusted) | $445.8M | $700.2M | $962.4M | $935.3M | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $253.5M | $401.7M | $446.2M | $490.9M | $504.4M | |
| Revenue Growth (YoY) | -14.86% | 58.45% | 11.08% | 10.01% | 2.74% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$88.8M | -$31.6M | -$25.5M | -$93.5M | -$132.3M | |
| Operating Income | $88.8M | $31.6M | $25.5M | $93.5M | $132.3M | |
| Net Interest Expenses | $11.3M | $27.5M | $32.2M | $18.9M | $9.6M | |
| EBT. Incl. Unusual Items | $88.8M | $278.2M | $25.5M | $93.5M | $132.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $23.7M | $60.9M | $5.3M | $22.5M | $31.6M | |
| Net Income to Company | $65.1M | $217.3M | $20.2M | $71M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $65.1M | $217.3M | $20.2M | $71M | $100.7M | |
| Basic EPS (Cont. Ops) | $1.20 | $4.28 | $0.33 | $1.44 | $2.14 | |
| Diluted EPS (Cont. Ops) | $1.19 | $4.23 | $0.33 | $1.43 | $2.12 | |
| Weighted Average Basic Share | $50.6M | $49.8M | $48M | $46.2M | -- | |
| Weighted Average Diluted Share | $51.2M | $50.3M | $48.1M | $46.8M | $45.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $114.7M | $401.9M | $227.8M | $301.5M | $309.2M | |
| Revenue (Reported) | $253.5M | $401.7M | $446.2M | $490.9M | $504.4M | |
| Operating Income (Reported) | $88.8M | $31.6M | $25.5M | $93.5M | $132.3M | |
| Operating Income (Adjusted) | $114.7M | $401.9M | $227.8M | $301.5M | $309.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.3B | $1.8B | $1.9B | $2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -$179.6M | -- | |
| Operating Expenses | -$338.1M | -$185.2M | -$246.6M | -$286.6M | -$434.6M | |
| Operating Income | $338.1M | $185.2M | $246.6M | $286.6M | $434.6M | |
| Net Interest Expenses | $42.2M | $77.8M | $128M | $92.1M | $45.4M | |
| EBT. Incl. Unusual Items | $338.1M | $431.8M | $246.6M | $107.1M | $432.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $84.1M | $99.3M | $57.5M | $29.6M | $102.5M | |
| Net Income to Company | $253.9M | $332.5M | $189.1M | $77.5M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $253.9M | $332.5M | $189.1M | $77.5M | $330.2M | |
| Basic EPS (Cont. Ops) | $4.65 | $6.32 | $3.58 | $1.29 | $6.87 | |
| Diluted EPS (Cont. Ops) | $4.60 | $6.25 | $3.54 | $1.27 | $6.80 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $445.8M | $700.2M | $962.4M | $935.3M | $1.2B | |
| Revenue (Reported) | $1B | $1.3B | $1.8B | $1.9B | $2B | |
| Operating Income (Reported) | $338.1M | $185.2M | $246.6M | $286.6M | $434.6M | |
| Operating Income (Adjusted) | $445.8M | $700.2M | $962.4M | $935.3M | $1.2B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.8B | $1.9B | $2B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -$179.6M | -$1.9M | -- | |
| Operating Expenses | -$185.2M | -$246.6M | -$286.6M | -$434.6M | -- | |
| Operating Income | $185.2M | $246.6M | $286.6M | $434.6M | -- | |
| Net Interest Expenses | $77.8M | $128M | $92.1M | $45.4M | -- | |
| EBT. Incl. Unusual Items | $431.8M | $246.6M | $107.1M | $432.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $99.3M | $57.5M | $29.6M | $102.5M | -- | |
| Net Income to Company | $332.5M | $189.1M | $77.5M | $124.4M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $332.5M | $189.1M | $77.5M | $330.2M | -- | |
| Basic EPS (Cont. Ops) | $6.32 | $3.58 | $1.29 | $6.87 | -- | |
| Diluted EPS (Cont. Ops) | $6.25 | $3.54 | $1.27 | $6.80 | -- | |
| Weighted Average Basic Share | $200.6M | $192.2M | $186.3M | $137.6M | -- | |
| Weighted Average Diluted Share | $202.8M | $193.9M | $188M | $184.6M | -- | |
| EBITDA | $88.3M | $209.2M | $248.2M | $260.9M | -- | |
| EBIT | $700.2M | $962.4M | $935.3M | $1.2B | -- | |
| Revenue (Reported) | $1.3B | $1.8B | $1.9B | $2B | -- | |
| Operating Income (Reported) | $185.2M | $246.6M | $286.6M | $434.6M | -- | |
| Operating Income (Adjusted) | $700.2M | $962.4M | $935.3M | $1.2B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $180.7M | $233.6M | $200.5M | $176.5M | $201.3M | |
| Short Term Investments | $3.5B | $2.6B | $3.2B | $182.9M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $8B | $5.1B | $3.4B | $3.3B | $2.1B | |
| Property Plant And Equipment | $76.5M | $109.1M | $121.7M | $251.9M | $88M | |
| Long-Term Investments | $7.8B | $4.8B | $3.1B | $3B | $1.9B | |
| Goodwill | $15.1M | -- | -- | -- | -- | |
| Other Intangibles | $2.2M | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $34.8B | $28.5B | $28.4B | $30.8B | $31.5B | |
| Accounts Payable | $7.7M | $24M | $33.2M | $23.7M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.2B | $1.2B | $1.5B | $885M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $15.6B | $11.1B | $10.8B | $10.5B | $7.3B | |
| Long-Term Debt | $980.8M | $765.6M | $755.8M | $864.4M | $620.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $31.6B | $25.4B | $25.2B | $27.4B | $27.9B | |
| Common Stock | $506K | $509K | $511K | $515K | $518K | |
| Other Common Equity Adj | -$47.7M | -$418.9M | -$362M | -$183.1M | -- | |
| Common Equity | $2.9B | $2.8B | $2.9B | $3.1B | $3.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.2B | $3.1B | $3.2B | $3.4B | $3.6B | |
| Total Liabilities and Equity | $34.8B | $28.5B | $28.4B | $30.8B | $31.5B | |
| Cash and Short Terms | $11.5B | $7.6B | $6.5B | $3.4B | -- | |
| Total Debt | $980.8M | $1B | $956.6M | $864.7M | $620.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $180.7M | $233.6M | $200.5M | $176.5M | $201.3M | |
| Short Term Investments | $3.5B | $2.6B | $3.2B | $182.9M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $8B | $5.1B | $3.4B | $3.3B | $2.1B | |
| Property Plant And Equipment | $76.5M | $109.1M | $121.7M | $251.9M | $88M | |
| Long-Term Investments | $7.8B | $4.8B | $3.1B | $3B | $1.9B | |
| Goodwill | $15.1M | -- | -- | -- | -- | |
| Other Intangibles | $2.2M | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $34.8B | $28.5B | $28.4B | $30.8B | $31.5B | |
| Accounts Payable | $7.7M | $24M | $33.2M | $23.7M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.2B | $1.2B | $1.5B | $885M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $15.6B | $10.9B | $10.8B | $10.5B | $7.3B | |
| Long-Term Debt | $980.8M | $752.8M | $755.8M | $864.4M | $620.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $31.6B | $25.4B | $25.2B | $27.4B | $27.9B | |
| Common Stock | $506K | $509K | $511K | $515K | $518K | |
| Other Common Equity Adj | -$47.7M | -$418.9M | -$362M | -$183.1M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.2B | $3.1B | $3.2B | $3.4B | $3.6B | |
| Total Liabilities and Equity | $34.8B | $28.5B | $28.4B | $30.8B | $31.5B | |
| Cash and Short Terms | $11.5B | $7.6B | $6.5B | $3.4B | -- | |
| Total Debt | $980.8M | $1B | $956.6M | $864.7M | $620.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $66.3M | $253.9M | $332.5M | $189.1M | $77.5M | |
| Depreciation & Amoritzation | $74.9M | $93.4M | $45.3M | $40.5M | $54.2M | |
| Stock-Based Compensation | $17.4M | $31.3M | $21.4M | $24.2M | $24.7M | |
| Change in Accounts Receivable | $10.7M | $154.1M | -$25.5M | -$78.6M | -$1.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.6B | $657.3M | $148M | $373.7M | $481.1M | |
| Capital Expenditures | $2.8M | $4.1M | $11.3M | $16.4M | $64.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.9B | $1.2B | $3.3B | -$1.8B | -$2.5B | |
| Dividends Paid (Ex Special Dividend) | $9.8M | $18.7M | $17.3M | $17.3M | $17.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $639.4M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$111M | -- | -$75M | -$200M | |
| Repurchase of Common Stock | -- | $150M | $115.3M | $105M | $81.5M | |
| Other Financing Activities | -$2M | -- | -- | -- | -- | |
| Cash From Financing | $5.1B | -$3.1B | -$6.4B | -$387.7M | $1.9B | |
| Beginning Cash (CF) | $4.4B | $9.2B | $7.9B | $5B | $3.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.8B | -$1.3B | -$2.9B | -$1.8B | -$54M | |
| Ending Cash (CF) | $9.2B | $7.9B | $5B | $3.2B | $3.2B | |
| Levered Free Cash Flow | $2.6B | $653.2M | $136.7M | $357.4M | $416.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $65.1M | $217.3M | $20.2M | $71M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $8.1M | $5.4M | $6.3M | $3.5M | -- | |
| Change in Accounts Receivable | $67.4M | -$23.3M | -$1.9M | $59.1M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $111M | -$66.1M | $187.7M | $18.4M | -- | |
| Capital Expenditures | $1.5M | $814K | $3.7M | $7.4M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1B | $3.6B | $318.4M | -$240.4M | -- | |
| Dividends Paid (Ex Special Dividend) | $4.3M | $4.3M | $4.3M | $4.3M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | $908.3M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $65.3M | $44.8M | -$26K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.7B | -$2.2B | -$1.5B | -$780.8M | -- | |
| Beginning Cash (CF) | $8.5B | $3.6B | $4.2B | $4.2B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$588.4M | $1.4B | -$949.9M | -$1B | -- | |
| Ending Cash (CF) | $7.9B | $5B | $3.2B | $3.2B | -- | |
| Levered Free Cash Flow | $109.5M | -$66.9M | $183.9M | $11M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $253.9M | $332.5M | $189.1M | $77.5M | -- | |
| Depreciation & Amoritzation | $93.4M | $45.3M | $40.5M | $54.2M | -- | |
| Stock-Based Compensation | $31.3M | $21.4M | $24.2M | $24.7M | -- | |
| Change in Accounts Receivable | $154.1M | -$25.5M | -$78.6M | -$1.6M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $657.3M | $148M | $373.7M | $481.1M | -- | |
| Capital Expenditures | $4.1M | $11.3M | $16.4M | $64.8M | $12.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1.2B | $3.3B | -$1.8B | -$2.5B | -- | |
| Dividends Paid (Ex Special Dividend) | $18.7M | $17.3M | $17.3M | $17.3M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $639.4M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$111M | -- | -- | -- | -- | |
| Repurchase of Common Stock | $150M | $115.3M | $105M | $81.5M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$3.1B | -$6.4B | -$387.7M | $1.9B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.3B | -$2.9B | -$1.8B | -$54M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $653.2M | $136.7M | $357.4M | $416.3M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $332.5M | $189.1M | $77.5M | $124.4M | -- | |
| Depreciation & Amoritzation | $10.6M | $8.7M | $10.9M | $23.7M | -- | |
| Stock-Based Compensation | $21.4M | $24.2M | $24.7M | $28.6M | -- | |
| Change in Accounts Receivable | -$25.5M | -$78.6M | -$1.6M | -$67M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $148M | $373.7M | $481.1M | $231.9M | -- | |
| Capital Expenditures | $11.3M | $16.4M | $64.8M | $12.9M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3.3B | -$1.8B | -$2.5B | -$1.9B | -- | |
| Dividends Paid (Ex Special Dividend) | $17.3M | $17.3M | $17.3M | $12.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$75M | -$200M | -$40.4M | -- | |
| Repurchase of Common Stock | $115.3M | $105M | $81.5M | $59.2M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$6.4B | -$387.7M | $1.9B | $1.5B | -- | |
| Beginning Cash (CF) | $21.2B | $15.7B | $13.7B | $7B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.9B | -$1.8B | -$54M | -$124M | -- | |
| Ending Cash (CF) | $18.3B | $13.9B | $13.6B | $6.5B | -- | |
| Levered Free Cash Flow | $136.7M | $357.4M | $416.3M | $219M | -- | |
Get TCBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TCBI
Sector
P/E ratio
15.37x
12.54x
PEG ratio
0.04x
0.32x
P/B ratio
1.39x
1.15x
Price / LTM sales
2.41x
1.86x
Growth Metrics
TCBI
Sector
Revenue growth
2.74%
5.54%
Earnings growth
48.64%
11.36%
Revenue (5-year growth)
10.01%
8.68%
Earnings forecast
$1.77
$0.64
Profitability
TCBI
Sector
Profitability FY 2025
--
--
Return on invested capital
6.75%
5.2%
Return on assets
1.04%
1.03%
Return on equity
9.4%
9.91%
Earnings Date
Last Earnings Date
Jan
22
Next Earnings Date
Apr
16
Estimated Next Earnings Date
Apr
23
Balance Sheet
TCBI
Sector
Total cash
$2.7B
$407.2M
Short term investments
$182.9M
$192.4M
Total assets
$31.5B
$3.1B
Long term debt
$620.6M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
